Robert Lutz - Nov 11, 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Chief Financial & Business Officer and Principal Accounting Officer
Signature
/s/Robert Matthew Lutz
Stock symbol
IBIO
Transactions as of
Nov 11, 2022
Transactions value $
$0
Form type
4
Date filed
11/15/2022, 07:33 AM
Previous filing
Aug 31, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBIO Common Stock Award $0 +100K +4746.54% $0.00 102K Nov 11, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 100,057 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 100,057 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 100,057 RSUs vest the earlier of: (i) July 1, 2023, or (ii) the successful achievement of the Corporation's 2023 objectives, as defined by the Board of Directors.

Remarks:

Chief Financial & Business Officer and Principal Accounting Officer